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Abstract
Chronic kidney disease (CKD) is highly prevalent worldwide. Patients with CKD on hemodialysis are more likely to present
behavioral changes and worse quality of life as a result of their routine and complications. They also have higher levels of
cytokines. The aim of this study is to assess the relationship between the inflammatory profile and quality of life measured by
KDOQL-SF36 in hemodialysis outpatients. Patients older than 21 years of age and on routine hemodialysis for at least 6 months
with treatment on a regular weekly basis were included and their anthropometric parameters and serum inflammatory markers
were evaluated. Thirty patients consented to participate. Homocysteine (Hcy) levels were correlated with worse glomerular
filtration rate (GFR; P=0.003) and creatinine (P=0.002). IL-6 was not correlated with worse nutritional status taking into account
body mass index (BMI; kg/m2; P=0.83). On the other hand, TNF-alpha was positively correlated with albumin (P=0.008),
nutritional status by BMI (P=0.04), and nutritional status by arm circumference area (P=0.04). IL-6 was correlated with activity
limitation (P=0.02) and Hcy with work status (P=0.04). Hcy was correlated with nutritional status and inflammatory markers. In
this population, the majority of the sections in KDOQL-SF36 were not correlated with cytokines levels.
Key words: Quality of life; Hemodialysis; Inflammation; Homocysteine
Introduction
The terminal stage of chronic kidney disease (CKD) is
characterized by a change in the routine of the individual
when dialysis treatment begins. Quality of life assessments
through the application of validated questionnaires is a
simple and important tool to measure the quality of treat-
ment and the individual’s acceptance of the disease (1,2).
Kidney Disease and Quality-of-Life Short-Form 36
(KDQOL-SF36) is a quality-of-life assessment tool for patients
with CKD undergoing hemodialysis and peritoneal dialysis,
able to subjectively assess some parameters of the patient’s
daily life that can reflect on their well-being and quality of
life. The questionnaire is self-applicable and has a multi-
item scale that evaluates health concepts, ranging from
limitations on physical activities and health problems, social
limitations due to physical and emotional problems, limita-
tions in day-to-day activities due to health problems, pain,
and mental health among others (3).
Dialysis patients may present a progressive reduction
of their cognitive and intellectual level, nutritional altera-
tions, a higher propensity to infections, and worsening of
quality of life, although an improvement of clinical and
laboratory conditions has been described (4). One of the
hypotheses for changes in cognitive function in CKD
patients is the increase in the synthesis of pro-inflammatory
mediators (1,4,5). Higher levels of proinflammatory cyto-
kines and other mediators of inflammation have been con-
sidered potential agents that favor the reduction of quality
of life in patients with CKD on dialysis (5). It is common for
patients in this clinical condition to present endotoxemia
and this, in parallel, further exacerbates renal dysfunction (6).
In addition, the release of inflammatory mediators dur-
ing hemodialysis treatment is indicated as an aggravating
factor for the increase in morbidity, mortality, and decline in
the subjective perception of overall quality of life (7). In our
study, we chose inflammatory markers that had already
been described in other studies. Saraheimo et al. (8) demon-
strated a close relationship between increased IL-6 levels
and C-reactive protein parallel to the severity of renal disease.
The augment of this cytokine is gradual and according to
the progress of CKD (9). Homocysteine (Hcy) is a thrombo-
genic factor that antagonizes nitric oxide. Besides, hyper-
homocysteinemia represents a risk factor for cardiovascular
diseases and mortality in patients with CKD, especially
when associated with high levels of CRP (10).
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This information raised the need to search for possible
correlations between the biochemical and inflammatory
changes present in terminal CKD and some parameters of
the KDQOL-SF36 questionnaire. The aim of the present
study was to apply the KDQOL-SF36 adapted to the
Portuguese language and to observe its association with
inflammatory and biochemical markers.
Material and Methods
Patients
This was an analytical and descriptive observational
study. All patients on hemodialysis treatment in Hospital
Mário Covas and Centro de Hemodiálise de Mauá
(SP, Brazil) were invited to take part in this study.
Patient inclusion criteria were: a) age greater than 21 years;
b) confirmed diagnosis of end-stage CKD; and c) having had
3 hemodialysis sessions per week for at least 6 months.
The exclusion criteria were: a) systemic infection or
hospitalization at the time of the interview; b) recent diagnosis
or undergoing treatment for neoplasia; and c) psychiatric
illness under treatment at the time of the interview. No patients
were excluded from the study; all the interviewees met the
inclusion criteria and thirty patients, after giving their written
informed consent, answered the KDQOL-SF36 validated
for the Portuguese language during the dialysis sessions.
The survey was registered with the local Ethics Committee
(No. 19795613.6.0000.0082/2013).
Variables
Blood samples were collected only once at the start
of the hemodialysis session on the day of the interview.
The inflammatory markers used were Hcy, ultra-sensitive
C-reactive protein (CRP), interleukin 6 (IL-6), TNF-a, and
serum ferritin. The adequacy assessment of the hemo-
dialysis was performed through the single pool kt/v value
of each session on the day of the interview. A value above
1.2 was considered a reference for adequacy.
For the estimation of glomerular filtration rate (GFR),
the simplified Modification of Diet in Renal Disease formula
was used and the result reported in mL min-1  (1.73 m2)-1.
The anthropometric measurements of each patient were
performed by a single nutritionist using triceps skinfold,
abdominal circumference, arm muscle circumference, and
body mass index (BMI) (kg/m2). The weight used was the
ideal dry weight in kilograms. The nutritional status of each
patient was also assessed by the serum albumin value.
Statistical analysis
All variables were analyzed descriptively. For quanti-
tative variables, analysis was performed by observing
the minimum and maximum values, and the calculation
of means, SD, and medians. For qualitative variables,
absolute and relative frequencies were calculated.
Using the Shapiro-Wilk test, it was verified that the
majority of the data did not present a normal distribution
(Po0.05) and were therefore reported as medians and
interquartile ranges. To analyze the association between
the variables, the Spearman correlation test was used.
Statistical significance was set at Pp0.05. The statistical
package used was Stata version 12.0 (StataCorp LP, USA).
Results
The percentage and average values of the demo-
graphic, anthropometric, and nutritional characteristics of
the patients are reported in Table 1.
The KDQOL-SF36 data of the items of interest are
reported in Table 2 as medians (25–75th percentiles).
Among the inflammatory markers studied, the highest
value was for ferritin, with a median of 305.5 ng/mL (224–
380). The medians for the other markers were TNF-a =
16.7 pg/mL (12.9–28.30), Hcy = 13.5 mmol/L (10.7–18.1),
IL-6 = 12.5 pg/mL (5–18), and CRP = 12.5 mg/L (6–20).
Evaluation of anthropometric parameters was made
through the measurement of abdominal circumference,
body mass index (BMI), triceps skinfold, and arm circum-
ference. For these parameters, the following medians
were obtained: abdominal circumference of 90.5 cm
(75–96); BMI of 25.2 kg/height (m)2 (21.5–27.3); triceps
Table 1. Demographic, anthropometric, and nutritional character-
istics of the study population.
Variable Value
Gender (M/F; %) 45/55
Age (years; average) 41.03
Ethnic group (Blacks/Caucasians; %) 43.3/56.4
Time in hemodialysis (months; average) 52.5
Kt/V (average) 1.34
Arterial hypertension (%) 93.3
Diabetes (%) 23.3
Etiology of chronic kidney disease (%)
Arterial hypertension 43.5
Diabetes 13.3
Glomerulonephritis 10.0
Autoimmune 3.3
Undefined 26.6
Chronic pyelonephritis 3.3
Interdialytic gain (%)
Up to 3 kg 53.4
From 3 to 5 kg 36.6
Above 5 kg 10.0
Nutritional status (%)
Malnourished 3.4
Eutrophic 46.6
Overweight 40.0
Obese 10.0
Data are reported as percentages or averages.
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skinfold thickness of 20 cm (15–25); and arm circumfer-
ence of 22.3 cm (21.2–24.4).
Statistical correlations between Hcy levels and work
status and between IL-6 levels and limitations due to
health problems were found. There was no relationship
between the other indices evaluated (Table 3).
Associations were found between triceps skinfold
thickness and work status (P=0.01), pain and triceps skin-
fold (P=0.05), and between arm circumference and patient
satisfaction (P=0.03) and physical functioning (P=0.04)
(Table 4).
The association between inflammatory markers and
dialysis adequacy parameters is described in Table 5.
Hcy was correlated with serum creatinine (P=0.002), GFR
(P=0.003), and dialysis time (P=0.02).
Among the inflammatory markers and nutritional param-
eters, there was a correlation between TNF-a and albumin
(P=0.008), nutritional status (P=0.04), and arm circumfer-
ence adequacy (P=0.01). TNF-a was the inflammatory
marker most commonly associated with nutritional param-
eters. There was an association between ferritin and
nutritional status (P=0.03), and between IL-6 and arm
circumference adequacy (P=0.02; Table 6).
There was no association between nutritional adequacy
parameters and albumin with triceps skinfold thickness
adequacy (P=0.66), with arm circumference adequacy
(P=0.92), and with BMI (P=0.37).
Discussion
CKD is commonly accompanied by a negative impact
on patient perception of health. These factors may also
reflect in other aspects such as nutrition, cognition, and
psychosocial factors (11). The KDQOL-SF36 is an instru-
ment for evaluating the perception of quality of life in
patients with end-stage renal disease and has a score
ranging from 0 to 100, allowing subjective measurement of
important variables for proper treatment follow-up (12).
Patients on hemodialysis commonly present weight
gain during the interdialytic period (13). Our data demon-
strated that 53.4% of the patients studied had an inter-
dialytic weight gain of 3 kg; 36.6% gained from 3 to 5 kg
and 10% had a weight gain of over 5 kg. In our evaluation,
we found no correlation between weight gain and the
other quality of life parameters as well as with inflamma-
tory markers.
When evaluating the nutritional profile and weight
gain of the individuals studied, we found that 3.4% of the
patients were malnourished and 46.6% were classified as
eutrophic. On the other hand, 40% were overweight and
10% were obese. Malnutrition apparently was not a predic-
tive factor for worse quality of life in this population (14,15).
Ferraz et al. (16), studying the nutritional status in
patients submitted to hemodialysis, found a correla-
tion between malnutrition and interdialytic weight gain.
However, they emphasized that findings should not be
generalized due to interferences of individual factors that
may reflect on nutrition and weight.
Tannor et al. (17), in an evaluation of the quality of life
in dialysis patients in South Africa, found that patients
on dialysis have a poor quality of life regardless of the
treatment being peritoneal dialysis or hemodialysis. The
parameters that differentiated the analysis were scores of
specific domains for each type of treatment, but in general,
both therapies resulted in reduction of quality of life.
Almutary et al. (18) demonstrated that sexual dysfunc-
tion affects approximately one third of dialytic renal patients
and is recurrent mainly in older individuals. On the other
hand, it has been reported that dialysis patients have
difficulty in feeling comfortable and having a satisfactory
sex life due to the use of catheters and the discomfort
caused by generalized pain (17). Thus, we believe that
the pain variable is one of the preponderant factors
that interferes in the other variables of quality of life
perception.
Raghavan et al. (19) state that pain is a symptom that
increases in parallel with the progression of kidney disease
and grows exponentially as the patient ages. The authors
suggest that these patients initiate pain-supportive care
that does not affect renal disease progression. Moreover,
pain may also reflect a limitation to perform essential
Table 2. Medians for items of the kidney disease quality of life
short form 36 (KDQOL-SF 36) questionnaire.
Quality of life Median
(25–75%)
Chronic renal failure – specific domains
Patient satisfaction 5.5 (5–6)
Dialysis staff encouragement 4 (2–6)
Social support 7 (6–8)
Sleep 16 (13–18)
Sexual function 2 (2–3)
Quality of social interactions 9 (7–10)
Cognitive function 5 (3–7)
Work status 3 (3–3)
Burden of kidney disease 14 (11–16)
Effects of kidney disease 18 (13–20)
List of symptoms/problems 16.5 (14–25)
Total 100
KDQOL-SF-36
Mental health 19 (17–21)
Limitations due to emotional health problems 5.5 (4–6)
Social functioning 6 (6–6)
Energy/Fatigue 15 (17–13)
Pain 3 (2–4)
Perception of general health 17 (19–13)
Physical functioning 27 (24–28)
Limitations due to physical health problems 7 (6–8)
Total 99.5
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activities, as verified in the parameter ‘‘limitations due to
physical health problems’’ (6–11).
The parameters with the best indices were: the
‘‘effects of kidney disease’’, ‘‘list of symptoms/problems’’,
‘‘sleep’’, and the ‘‘perception of the burden of kidney
disease’’. The variables ‘‘cognitive function’’, ‘‘limitations
due to emotional health problems’’, and ‘‘social function-
ing’’ obtained the lowest scores. Studies have suggested
that one of the possible determinants of cognition loss
in these patients is the decline in GFR and increased
synthesis of proinflammatory mediators (1,20–22).
A study in a rat model of chronic renal failure by 5/6
nephrectomy found an elevation of proinflammatory cyto-
kines. The authors suggest that this increase is related to
the decrease in cognition in CKD due to the detection of
proinflammatory cytokines in specific nuclei of the central
nervous system (23).
Our study found that Hcy was correlated with the
‘‘work status’’ variable and IL-6 levels with the variable
‘‘limitations due to health problems’’. Hcy participates
in the physiopathology of cardiovascular diseases (23),
Alzheimer’s (24), depression (25), and in kidney disease (26).
All of these pathologies are directly involved in loss of
quality of life and limitations due to these health problems,
which may directly reflect on performance at work and
other social activities.
When analyzing the relationship between anthro-
pometric data and the same inflammatory mediators, we
found that there was a significant correlation between
abdominal circumference and ferritin, and between BMI
and both CRP and ferritin values. ‘‘Triceps skinfold thick-
ness’’ was correlated with values of TNF-a. There is no
data in the literature on the relationship between meas-
urements of abdominal circumference or BMI and ferritin
levels in end-stage renal patients. It is possible that the
nutritional status of the studied population directly influenced
this interaction.
There is evidence indicating the participation of
hyperhomocysteinemia in the pathophysiology of kidney
disease (26). Foucher et al. (27), reporting the relationship
between Hcy and serum creatinine levels, showed that the
increase in Hcy is much greater than the elevation of
creatinine, making it clear that Hcy alterations progress
more rapidly than alterations in serum creatinine levels in
kidney patients. The authors also report that these factors
may contribute significantly to an increased mortality
rate and they attribute this to the increased release of
inflammatory mediators.
Table 3. Spearman’s correlation coefficients between quality of life and inflammatory markers.
Quality of life Inflammatory markers
TNF-a IL-6 CRP Hcy Ferritin
Chronic renal failure – specific domains
Patient satisfaction 0.165 0.083 –0.156 –0.052 0.026
Dialysis staff encouragement –0.146 –0.034 0.358 0.053 0.214
Social support 0.014 0.108 0.092 –0.016 –0.105
Sleep 0.234 –0.132 –0.116 –0.315 0.190
Sexual function –0.182 0.038 –0.132 0.031 –0.031
Quality of social interactions –0.036 –0.110 –0.038 0.053 0.100
Cognitive function 0.075 –0.004 0.084 –0.279 0.033
Work status 0.114 0.309 0.259 –0.374* –0.106
Burden of kidney disease 0.171 0.075 –0.019 –0.346 0.055
Effects of kidney disease 0.123 0.161 0.300 0.061 0.328
List of symptoms/problems 0.032 0.064 0.202 –0.026 0.144
KDQOL-SF 36
Mental health –0.130 –0.319 0.008 0.264 0.110
Limitations due to emotional health problems –0.026 –0.180 –0.172 –0.277 –0.001
Social functioning 0.023 0.268 0.313 –0.136 –0.007
Energy/Fatigue 0.210 –0.002 0.214 0.228 –0.007
Pain –0.035 0.084 0.184 0.042 0.061
Perception of general health –0.161 0.108 0.205 0.021 0.022
Physical Functioning –0.174 –0.216 –0.058 0.018 –0.005
Limitations due to physical health problems 0.358 0.404** –0.147 –0.266 0.023
Data are reported as Spearman’s correlation coefficient (rho). TNF-a: tumor necrosis factor alpha; IL-6: interleukin 6; CRP: ultra-
sensitive C-reactive protein; Hcy: homocysteine; KDQOL-SF 36: kidney disease quality of life short form 36 questionnaire. *Po0.05;
**Po0.01.
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Table 5. Spearman’s correlation coefficients between inflammatory markers and dialysis adequacy parameters.
Inflammatory markers Dialysis adequacy parameters
Kt/v Urea Creatinine GFR Number of fistulas Number of catheters Dialysis time
TNF-a 0.203 –0.155 –0.155 0.113 0.031 0.136 –0.079
IL-6 –0.132 –0.067 –0.180 0.123 –0.295 –0.024 –0.118
CRP –0.163 0.015 0.150 –0.176 –0.199 0.09 –0.401*
Hcy –0.175 0.257 0.538** –0.518** 0.173 0.149 0.411*
Ferritin –0.115 0.047 0.126 –0.170 –0.051 0.217 0.145
Data are reported as Spearman’s correlation coefficient (rho). GFR: glomerular filtration rate; TNF-a: tumor necrosis factor alpha; IL-6:
interleukin 6; CRP: ultra-sensitive C-reactive protein; Hcy: homocysteine. *Po0.05; **Po0.01.
Table 6. Spearman’s correlation coefficients between inflammatory markers and nutritional parameters.
Inflammatory markers Nutritional parameters
Albumin Nutritional status Triceps skinfold adequacy Arm circumference adequacy
TNF-a –0.474* 0.361* 0.371* –0.128
IL-6 –0.424* 0.224 0.353 –0.002
CRP –0.375* 0.419* 0.490** 0.308
Hcy 0.079 0.178 –0.194 0.200
Ferritin –0.162 0.388* –0.131 0.153
Data are reported as Spearman’s correlation coefficient (rho). TNF-a: tumor necrosis factor alpha; IL-6: interleukin 6; CRP: ultra-
sensitive C-reactive protein; Hcy: homocysteine. *Po0.05; **Po0.01.
Table 4. Spearman’s correlation coefficients between quality of life and anthropometric parameters.
Quality of life Anthropometric parameters
Abdominal circumference BMI Triceps skinfold Arm circumference
Chronic renal failure – specific domains
Patient satisfaction –0.254 –0.136 0.124 –0.378*
Dialysis staff encouragement 0.302 0.114 –0.311 0.318
Social support 0.033 –0.161 0.253 –0.322
Sleep –0.231 –0.150 –0.204 –0.053
Sexual function –0.193 –0.298 –0.325 –0.085
Quality of social interactions –0.193 –0.011 0.141 –0.207
Cognitive function 0.011 –0.013 –0.031 –0.123
Work status 0.072 0.230 0.467*** –0.089
Burden of kidney disease 0.025 0.059 0.116 0.099
Effects of kidney disease 0.016 0.166 –0.090 –0.072
List of symptoms/problems –0.233 0.036 –0.136 0.029
KDQOL-SF 36
Mental health 0.161 0.269 0.149 0.121
Limitations due to emotional health problems –0.231 –0.146 –0.019 –0.018
Social functioning 0.096 0.051 0.165 0.266
Energy/Fatigue 0.229 0.354 0.282 0.044
Pain 0.075 0.011 –0.493** 0.335
Perception of general health 0.103 0.022 0.044 0.233
Physical Functioning –0.158 –0.254 0.084 –0.370*
Limitations due to physical health problems –0.120 –0.006 0.197 –0.047
Data are reported as Spearman’s correlation coefficient (rho). BMI: body mass index; KDQOL-SF 36: kidney disease quality of life short
form 36 questionnaire. *Po0.05; **Po0.01; ***Po0.001.
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Although the observed results contribute to future
assessments of quality of life in patients during hemo-
dialysis treatment, it should be noted that the number of
patients studied may not allow generalization of the find-
ings. In addition, a one-time blood sample from patients
treated in a single center may limit the generalizability and
reliability of the results. Multiple hypotheses were tested,
and the small sample size did not allow correcting P-values.
Therefore, our study may have a high probability for global
type I error.
In conclusion, Hcy was directly related to nutritional
status, creatinine, and inflammatory markers. In the studied
population, most sections of the KDQOL-SF36 were not
correlated with inflammatory cytokine levels.
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